George Mason University

Research & Economic DevelopmentOffice of Research & Economic Development

Skip navigation

Research Focus

At Mason, our research mission is to create a safer, more sustained world with extended life quality. We have strategically assembled the following areas that encompass communities of practice whose knowledge and research are oriented towards this goal. Our Research Focus profiles these communities in an effort to foster interdisciplinary research explorations and to facilitate access to both individuals and centers of expertise.

Spotlighting Research

Check out our Spotlight on current and past research projects at Mason.

This week: Preserving Biodiversity in the Amazonian Jungle

Last week: When Mason Talks, the Washington Media Listens

Researcher Profiles

The researcher profiles present our Emerging Researcher, Scholar, Creator awardees and their current research initiatives.

Mason Research 2010 Mason Research 2011 Mason Research 2012 Mason Research 2013 Mason Research Magazine

Mason Research is an annual magazine produced by the Office of Research and Economic Development and the Office of University Relations. For recent featured articles about research at Mason. (2013 Online)

A collage of Mason Research magazine covers ranging from 20010 to 2013.

Vikas Chandhoke is the new VP of Research and Economic Development

Vikas Chandhoke was appointed by George Mason University Provost Peter Stearns to the position of vice president for research and economic development, effective June 26. ...More

Finance Professor Studies Investment Opportunities in Emerging Market

... Alexander Philipov, assistant professor of finance at George Mason University's School of Management, has new research, recently published in the Review of Asset Pricing Studies, that offers portfolio managers a better way to measure the potential returns for investing in international markets. ...More

Funded by Volleyball Tournaments, Breast Cancer Pilot Study Succeeds

...The pilot study is the first of its kind to utilize novel protein activation mapping technology along with the genomic fingerprint of cancer as a way to find the most effective treatment. The trial was announced at the annual meeting of the American Society of Clinical Oncology and is expected to expand into phase two this month. ...More